权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

IMMUNOLOGICAL CONSEQUENCES OF TRANSFUSION

输血的免疫学后果

基本信息

批准号：
6537352
负责人：
LOREN D. FAST
金额：
$ 20.45万
依托单位：
RHODE ISLAND HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
起止时间：
1999-04-01 至 2003-03-31
项目状态：
已结题

项目摘要

Transfusion of blood products has been shown to impact a number of the recipient immune responses. The immunological consequences of transfusion include the production of alloantibodies, increased incidence of bacterial infection, increased relapse rates for at least some kinds of tumors, transfusion-associated graft-versus-host disease, increased survival of organ allografts, induction of anti-leukemic responses and reversal of some cases of spontaneous recurrent abortions. Although donor blood and recipient have been matched for blood group antigens, they are not routinely typed for HLA antigens. Thus in almost all cases, the transfusion results in the introduction of alloantigens to the recipients. The goal of the studies is to define the mechanisms regulating recipient immune responses to alloantigen in order to understand how transfusion can influence immune responses and how to best regulate these responses. One approach to study the recipient responses to alloantigen is to study the responses which are responsible for the elimination of the allogeneic donor cells. Recipient CD8+ and B cells are responsible for the elimination of allogeneic donor cells in a murine model sytem. Optimal responses by these cells requires help from CD4+ cells. The most rapid recipient responses were in response to activated donor CD4+ cells acting as alloantigen presenting cells. The proposed experiments will examine the relative importance of this novel pathway by comparing the role of donor CD4+ cells and macrophages as antigen presenting cells. These donor cell populations will be compared by measuring the minimum number of each type of donor cell that is required for recipient immune responses, the interactions that are important in activation of recipient effector responses for each type of cell and how the immune responses generated by these cells regulate other immune responses.

血液制品的输血已被证明会影响许多受体的免疫反应。输血的免疫学后果包括产生同种抗体、增加细菌感染的发生率、增加至少某些类型肿瘤的复发率、输血相关的移植物抗宿主病、增加器官同种异体移植物的存活率、诱导抗白血病反应和逆转某些自发复发性流产病例。尽管供体血液和受体的血型抗原已经匹配，但它们并不常规地进行HLA抗原分型。因此，在几乎所有的情况下，输血都会导致同种异体抗原进入受体。这些研究的目的是确定调节受体对同种异体抗原的免疫应答的机制，以了解输血如何影响免疫应答以及如何最好地调节这些应答。研究受体对同种异体抗原的反应的一种方法是研究负责消除同种异体供体细胞的反应。CD8+和B细胞负责消除小鼠模型系统中的同种异体供体细胞。这些细胞的最佳反应需要CD4+细胞的帮助。最快速的受体反应是对作为同种异体抗原呈递细胞的活化供体CD4+细胞的反应。拟议的实验将通过比较供体CD 4+细胞和巨噬细胞作为抗原递呈细胞的作用来检查这种新型途径的相对重要性。将通过测量受体免疫应答所需的每种类型的供体细胞的最小数量、在激活每种类型细胞的受体效应物应答中重要的相互作用以及这些细胞产生的免疫应答如何调节其他免疫应答来比较这些供体细胞群。